Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2026.1767981 Mini Review Dual action of herbal compounds in Klebsiella pneumoniae infection and associated inflammatory diseases SaqibUzma 1 * Writing – original draft RatlamwalaSakina 1 Methodology Writing – original draft KibeNidhi 1 Formal analysis Investigation Resources Writing – original draft BaigMirza S. 2 Writing – review & editing HajelaKrishnan 1 Writing – review & editing SharmaSadhana 3 * Conceptualization Writing – original draft Writing – review & editing School of Life Sciences, Devi Ahilya Vishwavidyalaya, Indore (MP), India Mehta Family School of Biosciences & Biomedical Engineering, Indian Institute of Technology Indore (IITI), Indore, India Department of Biochemistry, All India Institute of Medical Sciences, Patna, India Correspondence: Sadhana Sharma, drsadhanas@aiimspatna.org; Uzma Saqib, uzmas2024@gmail.com 23 02 2026 2026 17 1767981 15 12 2025 06 02 2026 05 02 2026 Copyright © 2026 Saqib, Ratlamwala, Kibe, Baig, Hajela and Sharma. 2026 Saqib, Ratlamwala, Kibe, Baig, Hajela and Sharma https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Klebsiella pneumoniae (Kp) is a multidrug-resistant (MDR) pathogen responsible for severe infections such as pneumonia, sepsis, and urinary tract infections. Its pathogenicity includes both bacterial virulence factors and host-driven inflammatory responses thereby complicating treatment outcomes. Herbal compounds (phytochemicals) have recently gained attention as promising dual-action therapeutic agents that target both infection and inflammation. Phytochemicals such as curcumin, berberine, quercetin, resveratrol, and several medicinal plant extracts have demonstrated an integrated ability to mitigate both infection as well as host inflammation in preclinical studies. Their ability to attenuate virulence, reduce oxidative stress, and regulate host immune signaling positions them as potential candidates for adjunctive therapy against Kp infections. Furthermore, phytochemical-antibiotic combinations demonstrate synergistic effects, enhancing bacterial clearance and reducing antibiotic dosage requirements. Overall, the dual action of phytochemicals makes them as valuable candidates for integrative therapies against Kp infections and related inflammatory diseases. Unlike the prior reviews, the present review uniquely focusses the dual antibacterial and immunomodulatory actions of plant-derived compounds against Kp. It adds a novel perspective integrating the therapeutic promise of phytochemicals with a systematic analysis of their translational limitations. Further, it provides a rational framework to guide future development of phytochemicals as potent and clinically viable therapeutics against Kp infections.

 disease herbal compounds infection inflammation Klebsiella pneumoniae phytochemicals therapeutics Indian Council of Medical Research 10.13039/501100001411 Department of Biotechnology, Ministry of Science and Technology, India 10.13039/501100001407 The author(s) declared that financial support was received for this work and/or its publication. US thanks the Department of Biotechnology; DBT-RA/2024-2025/Call-II/RA/29 for RA fellowship. SS, KH, MSB and NK acknowledge the generous support from the Indian Council of Medical Research (ICMR), New Delhi Project IIRPSG-2024-01-01505. KH and MSB acknowledge the generous support from Anusandhan National Research Foundation (ANRF) under the SAKSHAM program, PAIR grant No. ANRF/PAIR/2025/000018/PAIR, project development of non AMR inducing novel drug compounds from levofloxacin and its structural analogs. section-at-acceptance Microbial Immunology Introduction

Klebsiella pneumoniae (Kp), a Gram-negative opportunistic pathogen (1, 2), is a leading cause of pneumonia, sepsis, and urinary tract infections, particularly in hospitalized patients (3, 4). Infection severity is influenced by bacterial virulence along with host’s immune response (5). Recognition of bacterial components, especially lipopolysaccharide (LPS), by pattern recognition receptors such as Toll-like receptor 4 (TLR4) (6, 7), triggers downstream signaling cascades including NF-κB and Mitogen-activated protein kinase (MAPK) (8), leading to the production of pro-inflammatory cytokines (9). While this response is essential for bacterial clearance, excessive or uncontrolled activation can cause tissue damage, septic shock, and organ failure (10).

In this context, plant-derived natural compounds have emerged (11) as promising therapeutic agent (12) that act at the intersection of infection and immunity (13). Table 1 represents the list of phytochemicals along with their class, botanical source, MIC values and synergistic effect against Kp strain and cytotoxicity values. These phytochemicals not only exert direct antibacterial effects against Kp, such as disrupting cell membranes, inhibiting biofilm formation, and interfering with bacterial enzymes, but also modulate host inflammatory pathways (101). By targeting TLR4-mediated NF-κB activation, MAPK signaling, and inflammasome responses, plant compounds alleviate inflammation (102). This integrated antibacterial and immunomodulatory action positions plant-derived molecules as potential agents in the treatment of multidrug-resistant (MDR) Kp infections (103).

Phytochemicals against Klebsiella pneumoniae (Kp): chemical class, botanical source, MIC values, synergistic activity, and cytotoxicity profiles.

Antibacterial compounds Class Source MIC values Synergistic effect Cytotoxicity IC 50 value Reference
Allyl isothiocyanate Organosulphur Compound Cruciferous Vegetables like Mustard seeds, horseradish and wasabi 10- 1000 µg/ml _ 25- 50 µM (14, 15)
Resveratrol Stilbenoids Berries, Peanuts and Grapes 50 - > 500 µg/ml Enhances antimicrobial activity of polymixin B and colistin in combination with resveratrol. > 100 µM (16)(17)(16)
Coumarins derivatives Phenolic Compounds Mesua ferrea – _ 7-35 µM (18)
Berberine Alkaloids Barberry 16- 512 µg/ml Berberine enhances the potential of rifaximin.  250 µM (19)(20)(21)
Mahanimbine Curry Leaves 25- 200 µg/ml  _ (22) (23)
Piperine Black Pepper < 100 µg/ml _  >200 µM (24)(25)(26)
Propolis Flavanoids                 Poplar 2- 1000 µg/ml Enhances antimicrobial efficacy, reverses bacterial resistance, and permits lower drug doses. (27) (28)(29)
Quercetin Apples, Onion, Spinach and Tea 16–256 μg/mL  Quercetin enhances the efficacy of colistin against colistin resistant kp strains. >300 µM (30)(31)(32)(33)
Kaempferol kale, Spinach, Cabbage, Broccoli, Capers and Onions 16–256 μg/mL It functions as an adjuvant that counteracts bacterial resistance by blocking efflux pumps and enhancing membrane permeability, thereby enabling effective treatment with lower antibiotic doses. (34)(35)(36) 
Curcumin Turmeric 128-512μg/ml When used alongside antibiotics, curcumin improves bacterial eradication against multidrug-resistant (MDR) infections. 59-90 µM (37)(38)(39)(40)
Baicalein Chinease Skull-cap 32 – 512 µg/ml Significantly enhanced antibiotic activities when synergistically used with beta -lactams, tetracycline, and ciprofloxacin. (41) (42)(43)
Naringin Citrus fruits 0.5 – 1.0 mg/ml Naringin acts an anti-inflammatory adjuvant for the treatment of Kp infections.   (44). (45a)(46)
Kuwanon G Mulberry 8 - 20 µg/ml Enhanced antimicrobial activity of oxacillin or gentamicin by reducing MIC by 2 - 500 folds against MRSA. (47)(48)(49, 50)
Apigenin Parsley, Celery and Chamomile > 128 µg/ml _ (51)(52)
Rutin Buckwheat, Citrus fruits, Berries, Tea, and Capers 256 µg/ml Rutin reduces MIC value of amikacin by 16 times shows very high synergistic activity. (53)(54)(55)
Luteolin Celery, Green peppers, Carrots, Broccoli, and Thyme 31-128 µg/ml -- (56)(57)
Diadzein Soybeans 8- 16 µg/ml In gold nanoparticles formation, daidzein shows synergistic antimicrobial activity against carbapenem resistant kp strains.  (58)(59)(60) 
Genistein Soybeans Not reported – (61) 
Catechins Tea 8- 16 µg/ml In combination with antibiotics, reduce resistance in MRSA (62)(63)(64) 
Narigenins Citrus fruits 200- 1024 µg/ml Naringenin revsrses colistin resistance against multi-drug resistant kp strains. (65) (66)
Chalcones Licorice 40-80 µg/ml : (67)(68) 
Galangin Galangal (Ginger family) 62.5 - 125 µg/ml Acts as a resistance - modifying agent against bacteria by inhibiting bacterial efflux pumps and increasing membrane permeability, which allows for lower drug doses of antibiotics. (49)(50)(69)(70)
Eugenol Clove, Basil and Bay leaf 200 µg/ml Combination of colistin and eugenol has a significant synergistic antibacterial effect and reverses the sensitivity of colistin resistant Klebsiella strains. (71) (72)(73)
Geraniin  Terpenes        Geranium 1.25 mg/ml : (74)(75)
Linalool Lavender and coriander (76) 11,250 μg/ml Along with meropenem MIC reduces to half and act as potential adjuvant for antibiotics against klebsiella infections. (76)(77)
Terpinen-4-ol Tea Tree oil   25 mM -  (78)(79)(80)
Menthol Mint  2 mg/ml -  (81)(82)
Citral  Lemongrass  75-150 μg/ml Interacts synergistically with norfloxacin against MRSA (83)(84) 
Citronellal Citronella grass, Lemon grass 12.8 mg/ ml Along with antimicrobial peptides citronellal acts as a adjuvant to kill antibiotic resistant Klebsiella strains (85)(86)(87)
Camphor Camphor laurel 57.63 mg/ml _ (88)(9.)
Carvone Caraway (89a) 6 - 60 µg/ml _ (89a)(90)(89b)
Thymol Thyme, Ajowan 475 µg/ml Thymol and Carvacrol in combination with antibiotics shows synergistic effect against Klebsiella. 1.15 mM (91)(92.)93a)
Carvacrol Oregano, Thyme and Savory 279 µg/ml Thymol and Carvacrol in combination with antibiotics show synergistic effect against Klebsiella. (91)(93)
1,8-cineol (eucalyptol) Eucalyptus 2 - 440 mg/ml Eucalyptol as a major constituent of essential oils in combination with antibiotics shows enhanced antibacterial properties. 7.31 mM (94a)(95)(96)(94b)
Myristicin Nutmeg 0.5 % v/v _ (97) (98)(9.)
Diterpenes (Ferruginol) Chamaecyparis lawsoniana 25-250 µg/ml : (99)(100)

This table compiles antibacterial plant-derived compounds, detailing their botanical sources and chemical classes. It reports the minimum inhibitory concentration (MIC) values required to inhibit Kp strains. In addition, the table highlights reported synergistic effects of these compounds when used in combination with conventional antibiotics, including their ability to enhance antibiotic efficacy, reduce antibiotic MIC values, and potentially reverse multidrug resistance (MDR). Where available, cytotoxicity data are also provided, expressed as IC values against human cell lines.

Kp virulence has massively disseminated globally in the recent years, although their epidemiology and clinical impact vary considerably across regions. Certain countries, including Israel, Greece, and Colombia, have progressed to endemic transmission (104), whereas others, such as Australia, New Zealand, and Canada, predominantly report imported cases. In regions with a high disease burden, the spread has largely been driven by clonal expansion of Kp, most commonly associated with the globally dominant ST258 lineage (105). In contrast, some countries, including the United Kingdom ST258 lineage, have experienced dissemination primarily through plasmid spread rather than clonal expansion (106). International travel has played a significant role in the introduction of Kp carbapenemase (KPC)-producing strains, particularly through intercontinental movement between the United States and Europe. Further, the emergence of multidrug-resistant (MDR) Kp represents a serious and escalating clinical challenge, particularly in healthcare settings where it frequently causes difficult-to-treat infections due to resistance to multiple antibiotic classes (107).

The management of Kp infections remains a major challenge in clinical infectious disease practice. High mortality rates, coupled with the frequent occurrence of nosocomial transmission, significantly complicate treatment outcomes even in the presence of antibiotic therapy. Current therapeutic approaches against Kp include new-generation β-lactam/β-lactamase inhibitor combinations like ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam, and cefiderocol (108, 109). Conventional agents such as aminoglycosides, and carbapenems etc are increasingly reserved for combination therapy due to toxicity and resistance concerns (110). In parallel, non-traditional strategies, including bacteriophage therapy, nanoparticle-based drug delivery, and anti-virulence approaches, are under active preclinical and early clinical investigation (111, 112).

Beyond clinical consequences, Kp imposes a profound economic and healthcare burden, particularly in low- and middle-income countries, where limited access to effective antimicrobial treatment and weaker healthcare infrastructures contribute to higher morbidity, mortality, and associated costs. Inadequate healthcare infrastructure, limited diagnostic capacity, and shortages of trained healthcare personnel further hinder effective surveillance, timely diagnosis, and appropriate treatment. Together, these economic and systemic constraints enhance the global impact of Kp and highlight the urgent need for improved antimicrobial therapy, affordable therapeutic options, and strengthened healthcare systems worldwide (113).

Unlike previous reviews that primarily address either the epidemiology of antimicrobial resistance or the antibacterial activity of natural products against Kp (110, 114), the present review uniquely integrates the dual antibacterial and immunomodulatory actions of plant-derived compounds with a critical evaluation of their translational limitations. By bridging mechanistic efficacy with clinical feasibility, this work provides a rational framework to guide the development of phytochemicals as adjunctive or alternative therapeutics against multidrug-resistant Kp.

 Dual action of plant-derived compounds against Kp infection Direct antibacterial activity

A wide selection of plant-derived compounds has demonstrated significant antibacterial activity against Kp, including MDR. Alkaloids such as berberine (BBR) inhibit bacterial growth by intercalating with DNA (115) and disrupting biofilm formation (116), while flavonoids like rutin exhibit both antibacterial and antioxidant effects, interfering with membrane integrity and reactive oxygen species (ROS) generation (117). Phenolic compounds and monoterpenes, including thymol, carvacrol, and 1,8-cineol, act primarily by disrupting bacterial membranes and inhibiting biofilm formation. Allyl isothiocyanate from Brassicaceae plants inhibits key enzymes and flagella-mediated movement in Kp (118, 119). Resinous substances like propolis, as well as herbal extracts from species such as Rhazya stricta and Acorus calamus, have also shown strong antibacterial and antibiofilm effects, sometimes targeting specific resistance mechanisms like NDM-1 (120). Traditional herbal formulas combining multiple plant extracts further enhance antibacterial efficacy through synergistic mechanisms (121). Collectively, these phytochemicals act via multiple pathways, including membrane disruption, biofilm inhibition, enzyme interference, and modulation of bacterial gene expression, highlighting their potential as alternative or adjunctive therapies against Kp infections.

 Modulation of inflammatory pathways

Plant-derived natural compounds also inhibit Kp infection by modulating inflammatory pathways. As discussed above, alkaloids like BBR, besides exhibiting direct antibacterial activity also regulate the NLRP3 inflammasome (122). It markedly suppressed the expression of NLRP3 inflammasome components in macrophages, thereby limiting M1 polarization and the associated inflammatory response (122).

Flavonoids such as quercetin and kaempferol derivatives reduce oxidative stress and suppress TLR4-mediated NF-κB and MAPK activation, thereby attenuating cytokine overproduction (123). Similarly, curcumin inhibits the TLR4-MyD88 interaction, preventing NF-κB nuclear translocation (124), while resveratrol and baicalein suppress MAPK phosphorylation, thereby ameliorating lung inflammation (125, 126). Other phytochemicals, including thymol, carvacrol, and 1,8-cineol, not only exhibit direct antibacterial activity against Kp but also indirectly attenuate inflammation by reducing bacterial load and preventing excessive immune activation (127, 128). Traditional herbal formulas combining multiple plant extracts enhance antibacterial and anti-inflammatory efficacy through synergistic mechanisms. Naringin (NAR), a flavonoid from pummelo peel inhibits NF-κB signaling in alveolar macrophages, reduces neutrophil recruitment, lowers IL-6 and TNF-α, and ameliorates lung inflammation and fibrosis during Kp infection (45b). Andrographis paniculata extracts showed inhibitory activity on growth and biofilm formation of MDR Kp strains along with suppressing AmpC β-lactamase expression (129).

The dual therapeutic potential of plant-derived compounds in Kp infections (Figure 1) is unequivocal. This integrated action positions phytochemicals as valuable candidates for adjunctive therapy, especially in the context of multidrug-resistant Kp infections (130), where controlling both bacterial growth and host-driven inflammation is critical for clinical outcomes (131).

Mechanism of action of plant-derived compounds against Kp. Plant-derived bioactive compounds exhibit a dual mode of action against Kp infection. First, they exert direct antibacterial effects by disrupting bacterial membrane integrity, inducing reactive oxygen species (ROS) generation, inhibiting biofilm formation, and intercalating bacterial DNA. Second, they modulate host inflammatory responses by suppressing MAPK and NF-κB signaling pathways and regulating NLRP3 inflammasome activation, thereby reducing infection-associated inflammation.

Infographic depicting plant-derived compounds' mechanisms against bacterial infections and inflammation, divided into direct antibacterial activity (disruption of bacterial membrane, ROS generation, DNA intercalation, and biofilm inhibition) and inflammatory pathways modulation (suppression of MAPK and NFk-B pathways, and regulatory control of NLRP3 inflammasome activation), with associated compounds and detailed pathway illustrations. Therapeutic implications

The combination of antimicrobial and immunomodulatory effects positions plant-derived compounds as highly valuable candidates in the treatment of Kp infections. Unlike conventional antibiotics that primarily focus on bacterial eradication, many phytochemicals exert a dual mode of action by directly inhibiting bacterial survival and, at the same time, modulating host immune responses to prevent excessive tissue damage 132). This duality is particularly important in the context of Kp, where hypervirulent strains often evade clearance through capsule-mediated resistance and induce overwhelming inflammatory cascades, leading to sepsis and organ dysfunction (9).

Importantly, this dual-action strategy offers a way to counteract the growing threat of multidrug resistance. Since phytochemicals often interfere with bacterial virulence factors such as biofilm formation, exopolysaccharide production, or capsule production, they can weaken pathogen defenses (133) without imposing strong selective pressure that drives resistance. At the same time, their immunomodulatory capacity reduces the severity of inflammation-driven complications (134), such as acute respiratory distress syndrome in severe pneumonia or septic shock during bloodstream infection. This makes them particularly attractive for use in severe and resistant infections where host inflammatory damage is often as dangerous as bacterial burden itself (135).

Furthermore, the integration of phytochemicals with conventional antibiotics holds strong therapeutic promise (136–138). Several studies indicate that natural compounds can restore or enhance antibiotic efficacy, for example, curcumin synergizing with β-lactams or flavonoids potentiating aminoglycoside activity against resistant Kp isolates (117, 139). Such combinations not only improve bacterial clearance but also reduce the required antibiotic dose, thereby limiting toxicity and delaying resistance development. Collectively, these features highlight plant-derived compounds as essential components of next-generation integrative therapies, where their antimicrobial and immunomodulatory effects are harnessed alongside standard antibiotics to achieve fruitful clinical outcomes against Kp infections (140).

 Limitations

Despite the promising antimicrobial and immunomodulatory potential of plant-derived compounds against Kp, several limitations restrict their translation into effective clinical therapies. A major challenge is their poor bioavailability and pharmacokinetics (141); many phytochemicals such as curcumin and quercetin show potent activity in vitro but are rapidly metabolized and eliminated in vivo, resulting in sub-therapeutic concentrations at the site of infection (142, 143). In addition, variability in plant extracts due to differences in species, growth conditions, harvesting, and extraction methods leads to inconsistent efficacy and reproducibility across studies. The potency of most plant-derived molecules is often weaker compared to standard antibiotics, with minimum inhibitory concentrations (MICs) that are sometimes too high to be clinically achievable without causing toxicity (144, 145). Moreover, while some compounds can inhibit Kp virulence, their action is usually partial and insufficient to inhibit the infection. Lack of standardized formulations (146a) and delivery systems further limits their therapeutic application (147), as many compounds degrade under physiological conditions or require advanced carriers (e.g., nanoparticles, liposomes) to reach effective levels (148, 149). Importantly, the absence of large-scale clinical trials means that safety, efficacy, and optimal dosing remain poorly defined, creating a gap between laboratory evidence and clinical practice (150). Finally, synergistic effects with antibiotics, though promising have not been systematically validated in vivo, raising concerns about drug-drug interactions or unpredictable outcomes (151, 152). Collectively, these limitations underscore the need for advanced formulation technologies, rigorous pharmacological testing, and well-designed clinical studies to establish plant-derived compounds as reliable adjuncts or alternatives for managing Kp infections.

These limitations of plant compounds against Kp or any other infectious agent can be addressed through nanotechnology-based delivery systems, standardization, structural modification, and rigorous clinical validation, making them as potent as well as potential agents against MDR infections.

 Future directions

It is important to investigate how phytochemicals modulate Kp virulence determinants and host immune pathways, including TLR4–NF-κB, MAPK, and inflammasome signaling. Future research on phytochemicals against Kp should focus on advancing target-guided studies integrating omics, bioinformatics, and systems-level analyses. Standardization of plant extracts and their formulations remain essential. Future efforts should emphasize reproducible extraction methods, compound purification, and structure–activity relationship (SAR) analyses to improve consistency, potency, and therapeutic predictability (146). In parallel, nanotechnology-based delivery systems such as nanoparticles and liposomal carriers should be systematically explored to overcome poor bioavailability, enhance tissue targeting, and improve pharmacokinetic profiles of promising compounds (153). Robust in vivo validation using clinically relevant Kp infection models is required to evaluate antibacterial efficacy, immunomodulatory effects, toxicity, and therapeutic efficacy. In addition, combination therapies comprising phytochemical-antibiotic combinations should be rigorously assessed in vivo to confirm efficacy and dosing along with minimizing the risk of adverse drug-drug interactions (154). Collectively, these directions provide a translational roadmap for developing plant-derived compounds as clinically viable therapeutics for the management of Kp infections.

 Conclusion

Accumulating evidence supports the therapeutic relevance of plant-derived compounds in managing Kp infections, particularly those caused by multidrug-resistant strains. These phytochemicals exert multimodal antibacterial effects, including disruption of bacterial membranes, inhibition of biofilm formation, interference with essential enzymatic processes, and modulation of resistance-associated pathways. Concurrently, many compounds act as host-directed immunomodulators, attenuating pathological inflammation through regulation of TLR4–NF-κB, MAPK, and NLRP3 inflammasome signaling, thereby limiting cytokine overproduction and oxidative tissue injury.

This dual antibacterial-immunomodulatory activity supports the use of phytochemicals as adjunctive therapeutics rather than standalone antimicrobials. By reducing bacterial burden while restraining excessive host inflammatory responses, these agents are particularly relevant in severe Kp-associated pneumonia, sepsis, and systemic infections. Representative phytochemicals, including curcumin, berberine, quercetin, resveratrol, and defined plant extracts, consistently demonstrate this integrated activity in preclinical models.

However, clinical translation remains constrained by poor bioavailability, suboptimal pharmacokinetics, and limited human safety data, as most evidence suggests from in vitro or in vivo studies. Addressing these barriers will require target-based studies, optimized formulation and delivery strategies, and rigorously designed clinical trials. In parallel, systematic evaluation of phytochemical-antibiotic combinations may enhance therapeutic efficacy while mitigating resistance development.

Overall, phytochemicals represent a rational, multi-targeted strategy to combat Kp infection. They do so by simultaneously addressing bacterial virulence and host-driven inflammatory pathology. Strategic integration of mechanistic insight, formulation science, and clinical validation will be essential to advance these agents toward clinically viable interventions against antibiotic-resistant Kp.

 Author contributions

US: Writing – original draft. SR: Methodology, Writing – original draft. NK: Formal analysis, Investigation, Resources, Writing – original draft. MB: Writing – review & editing. KH: Writing – review & editing. SS: Conceptualization, Writing – original draft, Writing – review & editing.

 Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author US declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

 Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 References Abbas R Chakkour M Zein El Dine H Obaseki EF Obeid ST Jezzini A . General overview of klebsiella pneumonia: epidemiology and the role of siderophores in its pathogenicity. Biol (Basel). (2024) 13:78. doi: 10.3390/biology13020078, PMID: 38392297 Podschun R Ullmann U . Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. (1998) 11:589–603. doi: 10.1128/cmr.11.4.589, PMID: 9767057 Choby JE Howard-Anderson J Weiss DS . Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives. J Intern Med. (2020) 287:283–300. doi: 10.1111/joim.13007, PMID: 31677303 Magill SS O’Leary E Janelle SJ Thompson DL Dumyati G Nadle J . Changes in prevalence of health care-associated infections in U.S. Hospitals. N Engl J Med. (2018) 379:1732–44. doi: 10.1056/NEJMoa1801550, PMID: 30380384 Liang Z Wang Y Lai Y Zhang J Yin L Yu X . Host defense against the infection of Klebsiella pneumoniae: New strategy to kill the bacterium in the era of antibiotics? Front. Cell Infect Microbiol. (2022) 12:1050396. doi: 10.3389/fcimb.2022.1050396, PMID: 36506034 Bhan U Ballinger MN Zeng X Newstead MJ Cornicelli MD Standiford TJ . Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PloS One. (2010) 5:e9896. doi: 10.1371/journal.pone.0009896, PMID: 20360853 Luo R Yao Y Chen Z Sun X . An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein–protein interactions. Cell Commun Signal. (2025) 23:142. doi: 10.1186/s12964-025-02149-4, PMID: 40102851 Tang Q Wang Q Sun Z Kang S Fan Y Hao Z . Bergenin Monohydrate Attenuates Inflammatory Response via MAPK and NF-κB Pathways Against Klebsiella pneumonia Infection. Front Pharmacol. (2021) 12:651664. doi: 10.3389/fphar.2021.651664, PMID: 34017253 Xu L Li J Wu W Wu X Ren J . Klebsiella pneumoniae capsular polysaccharide: Mechanism in regulation of synthesis, virulence, and pathogenicity. Virulence. (2024) 15:2439509. doi: 10.1080/21505594.2024.2439509, PMID: 39668724 Schulte W Bernhagen J Bucala R . Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—An updated view. Mediators Inflammation. (2013) 2013:165974. doi: 10.1155/2013/165974, PMID: 23853427 Cheng F Feng J Cao Z Duan Q Li H . Efficacy and safety of topical application of plant-based products on skin aging in healthy individuals: A systematic review and meta-analysis of randomized controlled trials. J Cosmet Dermatol. (2025) 24:e16710. doi: 10.1111/jocd.16710, PMID: 39654386 Kumar A P N Kumar M Jose A Tomer V Oz E . Major phytochemicals: recent advances in health benefits and extraction method. Molecules. (2023) 28:887. doi: 10.3390/molecules28020887, PMID: 36677944 Brindha PP . Role of phytochemicals as immunomodulatory agents: A review. Int J Green Pharm (IJGP). (2016) 10:1–18. doi: 10.22377/ijgp.v10i1.600 Priyadharshini V Anita B Shanthi A Suganthy M Gnanachitra M Latha TKS . Sustainable futures: Allyl isothiocyanate in agro-industry and food science. Physiol Mol Plant Pathol. (2025) 138:102668. doi: 10.1016/j.pmpp.2025.102668 Tarar A Peng S Cheema S Peng C-A . Anticancer activity, mechanism, and delivery of allyl isothiocyanate. Bioengineering. (2022) 9:470. doi: 10.3390/bioengineering9090470, PMID: 36135016 Liu L Yu J Shen X Cao X Zhan Q Guo Y . Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance. BMC Microbiol. (2020) 20:306. doi: 10.1186/s12866-020-01995-1, PMID: 33045992 Sahin Yaglıoglu A Eser F Tekin S Onal A . Antiproliferative activities of several plant extracts from Turkey on rat brain tumor and human cervix carcinoma cell lines. Front Life Sci. (2016) 9:69–74. doi: 10.1080/21553769.2015.1089949 Gkionis L Kavetsou E Kalospyros A Manousakis D Sanz M Butterworth S . Investigation of the cytotoxicity of bioinspired coumarin analogues towards human breast cancer cells. Mol Diversity. (2021) 25:307–321. doi: 10.1007/s11030-020-10082-6, PMID: 32328962 Ashraf A Khan MA Choudhury A Kumari S Alotaibi BS Noor S . Synergistic effect of the rifaximin-berberine combination against Klebsiella pneumoniae: RfaH targeting supported by MD simulation. Biomol Biomed. (2026). doi: 10.17305/bb.2026.13776, PMID: 41603697 Wojtyczka RD Dziedzic A Kępa M Kubina R Kabała-Dzik A Mularz T . Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative staphylococcus strains in vitro. Molecules. (2014) 19:6583–96. doi: 10.3390/molecules19056583, PMID: 24858093 Imenshahidi M Hosseinzadeh H . Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. (2019) 33:504–23. doi: 10.1002/ptr.6252, PMID: 30637820 Mondal P Natesh J Abdul Salam AA Meeran SM . Mahanimbine isolated from Murraya koenigii inhibits P-glycoprotein involved in lung cancer chemoresistance. Bioorganic Chem. (2022) 129:106170. doi: 10.1016/j.bioorg.2022.106170, PMID: 36174443 Nagappan T Ramasamy P Wahid MEA Segaran TC Vairappan CS . Biological activity of carbazole alkaloids and essential oil of murraya koenigii against antibiotic resistant microbes and cancer cell lines. Molecules. (2011) 16:9651–64. doi: 10.3390/molecules16119651, PMID: 22105714 Benayad S Wahnou H El Kebbaj R Liagre B Sol V Oudghiri M . The promise of piperine in cancer chemoprevention. Cancers (Basel). (2023) 15:5488. doi: 10.3390/cancers15225488, PMID: 38001748 Lwamba C Aboushanab SA Ambati RR Kovaleva EG . Innovative green approach for extraction of piperine from black pepper based on response surface methodology. Sustain Chem. (2023) 4:40–53. doi: 10.3390/suschem4010005 Alves FS Cruz JN de Farias Ramos IN do Nascimento Brandão DL da Silva Queiroz RN Silva GVda . Evaluation of antimicrobial activity and cytotoxicity effects of extracts of piper nigrum L. Piperine. Separations. (2023) 10:21. doi: 10.3390/separations10010021 Rana A Malik A Sobti RC . Anti-bacterial properties of propolis: A comprehensive review. Curr Microbiol. (2025) 82:479. doi: 10.1007/s00284-025-04456-y, PMID: 40858917 Esertaş Ü.Z. Inal N Can Z Kolaylı S . A promising antibacterial inhibition of propolis extracts against carbapenem-resistant bacteria isolated from clinical samples. Chem Biodiversity. (2025) 22:e00158. doi: 10.1002/cbdv.202500158, PMID: 40884830 Balasubramaniam AK Elangovan A Rahman MA Nayak S Swain D Babu HP . Propolis: A comprehensive review on the nature’s polyphenolic wonder. Fitoterapia. (2025) 183:106526. doi: 10.1016/j.fitote.2025.106526, PMID: 40204045 Lin Y Zhang Y Liu S Ye D Chen L Huang N . Quercetin rejuvenates sensitization of colistin-resistant escherichia coli and klebsiella pneumoniae clinical isolates to colistin. Front Chem. (2021) 9:795150. doi: 10.3389/fchem.2021.795150, PMID: 34900948 Ishida K Ito C Ohmori Y Kume K Sato KA Koizumi Y . Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil. Sci Rep. (2017) 7:2262. doi: 10.1038/s41598-017-02548-9, PMID: 28536445 Pal A Tripathi A . Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae. Microbial Pathogenesis. (2020) 143:104120. doi: 10.1016/j.micpath.2020.104120, PMID: 32169488 Baqer SH Al-Shawi SG Al-Younis ZK . Quercetin, the potential powerful flavonoid for human and food: A review. Front Biosci (Elite Ed). (2024) 16:30. doi: 10.31083/j.fbe1603030, PMID: 39344383 Setyawan HY Singh AK Roy A Pandit S Gill HS Rajeev M . A comprehensive review on Kaempferol as a therapeutic flavonoid against ESKAPE and multiple drug-resistant bacteria: Recent advances and challenges. Phytomedicine. (2026) Plus 6:100926. doi: 10.1016/j.phyplu.2025.100926 Zhou H Xu M Guo W Yao Z Du X Chen L . The antibacterial activity of kaempferol combined with colistin against colistin-resistant gram-negative bacteria. Microbiol Spectr. (2022) 10:e02265–22. doi: 10.1128/spectrum.02265-22, PMID: 36314964 A P K P Ia B Em P Dc P A C . Kaempferol: antimicrobial properties, sources, clinical, and traditional applications. Int J Mol Sci. (2022) 23. doi: 10.3390/ijms232315054, PMID: 36499380 Lara-Espinosa JV Barrios-Payán J Lozano-Ordaz V Mata-Espinosa D Becerril-Villanueva E Ponce-Regalado MD . Synergistic effects of curcumin and antibiotics against drug-sensitive and multidrug-resistant mycobacterium tuberculosis. Int J Mol Sci. (2025) 26:10414. doi: 10.3390/ijms262110414, PMID: 41226452 Kubizna M Dawiec G Wiench R . Efficacy of curcumin-mediated antimicrobial photodynamic therapy on candida spp.-A systematic review. Int J Mol Sci. (2024) 25:8136. doi: 10.3390/ijms25158136, PMID: 39125706 Karami-Zarandi M Ghale HEG Ranjbar R . Characterization of virulence factors and antibacterial activity of curcumin in hypervirulent klebsiella pneumoniae. Future Microbiol. (2022) 17:529–40. doi: 10.2217/fmb-2021-0222, PMID: 35322691 Hewlings SJ Kalman DS . Curcumin: A review of its’ Effects on human health. Foods. (2017) 6:92. doi: 10.3390/foods6100092, PMID: 29065496 Muniyasamy R Manjubala I . Synergistic combination of baicalein and rifampicin against Staphylococcus aureus biofilms. Front Microbiol. (2024) 15:1458267. doi: 10.3389/fmicb.2024.1458267, PMID: 39165570 Qin X Wu Y Zhao Y Qin S Ji Q Jia J . Revealing active constituents within traditional Chinese Medicine used for treating bacterial pneumonia, with emphasis on the mechanism of baicalein against multi-drug resistant Klebsiella pneumoniae. J Ethnopharmacology. (2024) 321:117488. doi: 10.1016/j.jep.2023.117488, PMID: 38008277 Chanchal DK Singh K Bhushan B Chaudhary JS Kumar S Varma AK . An updated review of Chinese skullcap (Scutellaria baicalensis): Emphasis on phytochemical constituents and pharmacological attributes. Pharmacol Res - Modern Chin Med. (2023) 9:100326. doi: 10.1016/j.prmcm.2023.100326 Jing X-H Zhao G-Y Wang G-B Huang Q-L Zou W-S Huang L-N . Naringin alleviates pneumonia caused by Klebsiella pneumoniae infection by suppressing NLRP3 inflammasome. BioMed Pharmacother. (2024) 170:116028. doi: 10.1016/j.biopha.2023.116028, PMID: 38113627 Zhao G Huang Q Jing X Huang L Liu C Pan X . Therapeutic effect and safety evaluation of naringin on klebsiella pneumoniae in mice. Int J Mol Sci. (2023) 24:15940. doi: 10.3390/ijms242115940, PMID: 37958922 Shilpa VS Shams R Dash KK Pandey VK Dar AH Ayaz Mukarram S . Phytochemical properties, extraction, and pharmacological benefits of naringin: A review. Molecules. (2023) 28:5623. doi: 10.3390/molecules28155623, PMID: 37570594 Aelenei P Rimbu CM Horhogea CE Lobiuc A Neagu A-N Dunca SI . Prenylated phenolics as promising candidates for combination antibacterial therapy: Morusin and kuwanon G. Saudi Pharm J. (2020) 28:1172–81. doi: 10.1016/j.jsps.2020.08.006, PMID: 33132710 Kizirgil A Demirdag K Ozden M Bulut Y Yakupogullari Y Asci Toraman Z . In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates. Microbiological Res. (2005) 160:135–40. doi: 10.1016/j.micres.2004.10.001, PMID: 15881830 Wu E Zhu Y Wei Q Lu H Zou Y Liu F . Inhibition mechanism of mulberry prenylated flavonoids sanggenone D/kuwanon G against α-glucosidase and the regulation of glucose via GLUT4 pathway. Nutrients. (2025) 17:1539. doi: 10.3390/nu17091539, PMID: 40362846 Wu Y Luo J Xu B . Insights into the anticancer effects of galangal and galangin: A comprehensive review. Phytomedicine. (2024) 135:156085. doi: 10.1016/j.phymed.2024.156085, PMID: 39353308 Akilandeswari K Ruckmani K . Synergistic antibacterial effect of apigenin with Î2-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus. Cell Mol Biol (Noisy-le-grand). (2016) 62:74–82. doi: 10.14715/cmb/, PMID: 28145860 McKay DL Blumberg JB . A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res. (2006) 20:519–30. doi: 10.1002/ptr.1900, PMID: 16628544 Miklasińska-Majdanik M Kępa M Wąsik TJ Zapletal-Pudełko K Klim M Wojtyczka RD . The direction of the antibacterial effect of rutin hydrate and amikacin. Antibiotics (Basel). (2023) 12:1469. doi: 10.3390/antibiotics12091469, PMID: 37760765 Amin MU Khurram M Khattak B Khan J . Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus. BMC Complement Altern Med. (2015) 15:59. doi: 10.1186/s12906-015-0580-0, PMID: 25879586 Semwal R Joshi SK Semwal RB Semwal DK . Health benefits and limitations of rutin - A natural flavonoid with high nutraceutical value. Phytochem Lett. (2021) 46:119–28. doi: 10.1016/j.phytol.2021.10.006 Almatroodi SA Almatroudi A Alharbi HOA Khan AA Rahmani AH . Effects and mechanisms of luteolin, a plant-based flavonoid, in the prevention of cancers via modulation of inflammation and cell signaling molecules. Molecules. (2024) 29:1093. doi: 10.3390/molecules29051093, PMID: 38474604 El-Shiekh RA Elhemely MA Naguib IA Bukhari SI Elshimy R . Luteolin 4′-neohesperidoside inhibits clinically isolated resistant bacteria in vitro and in vivo. Molecules. (2023) 28:2609. doi: 10.3390/molecules28062609, PMID: 36985581 Ubaid M Salauddin Shadani MA Kawish SM Albratty M Makeen HA . Daidzein from Dietary Supplement to a Drug Candidate: An Evaluation of Potential. ACS Omega. (2023) 8:32271–93. doi: 10.1021/acsomega.3c03741, PMID: 37780202 Paul Dzoyem J Hamamoto H Ngameni B Tchaleu Ngadjui B Sekimizu K . Antimicrobial action mechanism of flavonoids from Dorstenia species. Drug Discoveries Ther. (2013) 7:66–72. doi: 10.5582/ddt.2013.v7.2.66, PMID: 23715504 Pan J Zhang J Hu P Yao Z Zhang X Zhou T . Daidzein-decorated gold nanoparticles as a novel antimicrobial strategy against carbapenem-resistant enterobacteriaceae. Int J Nanomedicine. (2025) 20:7811–27. doi: 10.2147/IJN.S515798, PMID: 40551978 Sharifi-Rad J Quispe C Imran M Rauf A Nadeem M Gondal TA . Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. (2021) 2021:3268136. doi: 10.1155/2021/3268136, PMID: 34336089 Vuong QV Golding JB Nguyen M Roach PD . Extraction and isolation of catechins from tea. J Sep Sci. (2010) 33:3415–28. doi: 10.1002/jssc.201000438, PMID: 21049524 Gomes FMS da Cunha Xavier J dos Santos JFS de Matos YMLS Tintino SR de Freitas TS . Evaluation of antibacterial and modifying action of catechin antibiotics in resistant strains. Microbial Pathogenesis. (2018) 115:175–8. doi: 10.1016/j.micpath.2017.12.058, PMID: 29275130 Qin R Xiao K Li B Jiang W Peng W Zheng J . The combination of catechin and epicatechin gallate from fructus crataegi potentiates β-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo. Int J Mol Sci. (2013) 14:1802–21. doi: 10.3390/ijms14011802, PMID: 23325048 Alam MA Subhan N Rahman MM Uddin SJ Reza HM Sarker SD . Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. (2014) 5:404–17. doi: 10.3945/an.113.005603, PMID: 25022990 Mendez-Vilas A . Exploring microorganisms: recent advances in applied microbiology. Irvine, California (USA): BrownWalker Press. (2018). Liu M Du Y Gao D . Licochalcone A: a review of its pharmacology activities and molecular mechanisms. Front Pharmacol. (2024) 15:1453426. doi: 10.3389/fphar.2024.1453426, PMID: 39188947 Hussen NH Hussein LB Hasan AH Hamid SJ Abdl CO Sarkar B . Chalcone-related small molecules as potent antibacterial and antifungal agents: Design, synthesis, In vitro, and computational approaches. Aspects Mol Med. (2025) 5:100066. doi: 10.1016/j.amolm.2025.100066 Lee Y-S Kang O-H Choi J-G Oh Y-C Chae H-S Kim JH . Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus. J Microbiol. (2008) 46:283–8. doi: 10.1007/s12275-008-0012-7, PMID: 18604497 Pepeljnjak S Kosalec I . Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa. FEMS Microbiol Lett. (2004) 240:111–6. doi: 10.1016/j.femsle.2004.09.018, PMID: 15500987 Silva MV de Lima A da CA Silva MG Caetano VF de Andrade MF . Clove essential oil and eugenol: A review of their significance and uses. Food Bioscience. (2024) 62:105112. doi: 10.1016/j.fbio.2024.105112 Jafri H Khan MSA Ahmad I . In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans. Phytomedicine. (2019) 54:206–13. doi: 10.1016/j.phymed.2018.10.005, PMID: 30668370 Li A Wang M Zhang Y Lin Z Xu M Wang L . Complete genome analysis of Bacillus subtilis derived from yaks and its probiotic characteristics. Front Vet Sci. (2023) 9:1099150. doi: 10.3389/fvets.2022.1099150, PMID: 36713867 Cai J Wang L Xu M Zhu S Chen Y Zhong J . Multi-target therapeutics of geraniin from Geranium wilfordii Maxim. and related species: Mechanisms and applications. J Ethnopharmacol. (2026) 356:120765. doi: 10.1016/j.jep.2025.120765, PMID: 41115485 Boakye Y Agyare C Hensel A . Anti-infective Properties and Time-Kill Kinetics of Phyllanthus muellerianus and its Major Constituent, Geraniin. Medicinal Chemistry: Curr Res. (2016) 6:95–105. doi: 10.4172/2161-0444.1000332 Pereira I Severino P Santos AC Silva AM Souto EB . Linalool bioactive properties and potential applicability in drug delivery systems. Colloids Surf B Biointerfaces. (2018) 171:566–78. doi: 10.1016/j.colsurfb.2018.08.001, PMID: 30098535 Yang S-K Yusoff K Ajat M Wee C-Y Yap P.-S.-X. Lim S.-H.-E. . Combinatorial antimicrobial efficacy and mechanism of linalool against clinically relevant klebsiella pneumoniae. Front Microbiol. (2021) 12:635016. doi: 10.3389/fmicb.2021.635016, PMID: 33815320 Prerna n Chadha J Khullar L Mudgil U Harjai K . A comprehensive review on the pharmacological prospects of Terpinen-4-ol: From nature to medicine and beyond. Fitoterapia. (2024) 176:106051. doi: 10.1016/j.fitote.2024.106051, PMID: 38838826 Johansen B Duval RE Sergere J-C . First evidence of a combination of terpinen-4-ol and α-terpineol as a promising tool against ESKAPE pathogens. Molecules. (2022) 27:7472. doi: 10.3390/molecules27217472, PMID: 36364298 Cheruvanachari P Pattnaik S Mishra M Pragyandipta P Naik P . Terpinen-4-ol, An Active Constituent of Kewda Essential Oil, Mitigates Biofilm Forming Ability of Multidrug Resistant Staphylococcus aureus and Klebsiella pneumoniae. J Biologically Active Products Nat. (2022) 12:406–20. doi: 10.1080/22311866.2022.2154264 Batool I Nisar S Hamrouni L Jilani M . Extraction, production and analysis techniques for menthol: A review. Ontario (ON), Canada: International Scientific Organization. (2018). Husain FM Ahmad I Mohammad S Ahmad E Tahseen Q Alshabib NA . Sub-MICs of Mentha piperita essential oil and menthol inhibits AHL mediated quorum sensing and biofilm of Gram-negative bacteria. Front Microbiol. (2015) 6:420. doi: 10.3389/fmicb.2015.00420, PMID: 26029178 Khasanah LU Ariviani S Purwanto E Praseptiangga D . Chemical composition and citral content of essential oil of lemongrass (Cymbopogon citratus (DC.) Stapf) leaf waste prepared with various production methods. J Agric Food Res. (2025) 19:101570. doi: 10.1016/j.jafr.2024.101570 Gupta P Patel DK Gupta VK Pal A Tandon S Darokar MP . Citral, a monoterpenoid aldehyde interacts synergistically with norfloxacin against methicillin resistant Staphylococcus aureus. Phytomedicine. (2017) 34:85–96. doi: 10.1016/j.phymed.2017.08.016, PMID: 28899514 Kumoro A Wardhani D Retnowati D Haryani K . A brief review on the characteristics, extraction and potential industrial applications of citronella grass (Cymbopogon nardus) and lemongrass (Cymbopogon citratus) essential oils. IOP Conf Series: Materials Sci Eng. (2021) 1053:12118. doi: 10.1088/1757-899X/1053/1/012118 Singh R Agrawal R . Antimicrobial activity of citronella essential oil on antimicro bial drug resistant bacteria from veterinary clinical cases. Clin Med Biochem Open Access. (2015) 1:106. doi: 10.4172/2471-2663.1000106 Silva SCLD Silva-Rodrigues G Bartolomeu-Gonçalves G Oliveira Filho A Medeiros CIS . Bactericidal effect of citronellal and molecular docking with KPC-2 of Klebsiella pneumoniae and PBP2A of Staphylococcus aureus. An. Acad Bras Ciênc. (2025) 97:e20250277. doi: 10.1590/0001-3765202520250277, PMID: 41124496 Usmani Q Jahan N Shafiquddin S . KAFUR (C. CAMPHORA L.)-AN UPDATED REVIEW OF ITS ETHNOPHARMACOLOGY, PHYTOCHEMISTRY AND PHARMACOLOGY review article. Int J Pharm Pharm Sci. (2022) 14:10–7. doi: 10.22159/ijpps.2022v14i10.45766 Pina LTS Serafini MR Oliveira MA Sampaio LA Guimarães JO Guimarães AG . Carvone and its pharmacological activities: A systematic review. Phytochemistry. (2022) 196:113080. doi: 10.1016/j.phytochem.2021.113080, PMID: 34999510 Orhan IE Ozcelik B Kan Y Kartal M . Inhibitory effects of various essential oils and individual components against extended-spectrum beta-lactamase (ESBL) produced by Klebsiella pneumoniae and their chemical compositions. J Food Sci. (2011) 76:M538–546. doi: 10.1111/j.1750-3841.2011.02363.x, PMID: 22417594 Salehi B Mishra AP Shukla I Sharifi-Rad M Contreras MDM Segura-Carretero A . Thymol, thyme, and other plant sources: Health and potential uses. Phytother Res. (2018) 32:1688–706. doi: 10.1002/ptr.6109, PMID: 29785774 Braga PC . Thymol: antibacterial, antifungal and antioxidant activities. Rome, Italy: CIC Edizioni Internazionali s.r.l. (2005). Farhadi K Rajabi E Varpaei HA Iranzadasl M Khodaparast S Salehi M . Thymol and carvacrol against Klebsiella: anti-bacterial, anti-biofilm, and synergistic activities—a systematic review. Front Pharmacol. (2024) 15:1487083. doi: 10.3389/fphar.2024.1487083, PMID: 39512827 Bariz K Trabelsi L Lahcene S Salem-Bekhit MM Elossaily GM Alzahrani HA . Evaluating the synergistic potency of essential oils and antibiotics against klebsiella pneumoniae BLSE strains. Cell Mol Biol (Noisy-le-grand). (2023) 69:198–206. doi: 10.14715/cmb/2023.69.3.29, PMID: 37300667 Puig-Herreros C Sanz JL García-Bernal D Rodríguez-Lozano FJ Murcia L Forner L . Comparative cytotoxicity of menthol and eucalyptol: an in vitro study on human gingival fibroblasts. Pharmaceutics. (2024) 16:521. doi: 10.3390/pharmaceutics16040521, PMID: 38675182 Juergens UR Dethlefsen U Steinkamp G Gillissen A Repges R Vetter H . Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med. (2003) 97:250–6. doi: 10.1053/rmed.2003.1432, PMID: 12645832 Seneme EF Dos Santos DC Silva EMR Franco YEM Longato GB . Pharmacological and therapeutic potential of myristicin: A literature review. Molecules. (2021) 26:5914. doi: 10.3390/molecules26195914, PMID: 34641457 El-Demerdash AS Alfaraj R Farid FA Yassin MH Saleh AM Dawwam GE . Essential oils as capsule disruptors: enhancing antibiotic efficacy against multidrug-resistant Klebsiella pneumoniae. Front Microbiol. (2024) 15:1467460. doi: 10.3389/fmicb.2024.1467460, PMID: 39282565 Smith ECJ Williamson EM Wareham N Kaatz GW Gibbons S . Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochemistry. (2007) 68:210–7. doi: 10.1016/j.phytochem.2006.10.001, PMID: 17109904 Lima A Arruda F Janeiro A Medeiros J Baptista J Madruga J . Biological activities of organic extracts and specialized metabolites from different parts of Cryptomeria japonica (Cupressaceae) – A critical review. Phytochemistry. (2023) 206:113520. doi: 10.1016/j.phytochem.2022.113520, PMID: 36544302 Saifi S Ashraf A Hasan GM Shamsi A Hassan M . Insights into the preventive actions of natural compounds against Klebsiella pneumoniae infections and drug resistance. Fitoterapia. (2024) 173:105811. doi: 10.1016/j.fitote.2023.105811, PMID: 38168570 Gray P Dunne A Brikos C Jefferies CA Doyle SL O′Neill LAJ . MyD88 adapter-like (Mal) is phosphorylated by Bruton’s tyrosine kinase during TLR2 and TLR4 signal transduction. J Biol Chem. (2016) 291:26240. doi: 10.1074/jbc.A116.508892, PMID: 27941071 Mitropoulou G Stavropoulou E Vaou N Tsakris Z Voidarou C Tsiotsias A . Insights into antimicrobial and anti-inflammatory applications of plant bioactive compounds. Microorganisms. (2023) 11:1156. doi: 10.3390/microorganisms11051156, PMID: 37317131 Boattini M Comini S Ricciardelli G Pastrone L Casale R Guarrasi L . Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections. Infection. (2025). doi: 10.1007/s15010-025-02716-4, PMID: 41436714 Castronovo G Clemente AM Antonelli A D’Andrea MM Tanturli M Perissi E . Differences in inflammatory response induced by two representatives of clades of the pandemic ST258 klebsiella pneumoniae clonal lineage producing KPC-type carbapenemases. PloS One. (2017) 12:e0170125. doi: 10.1371/journal.pone.0170125, PMID: 28081233 Fordham SME Mantzouratou A Sheridan E . The presence of an ESBL-encoding plasmid reported during a klebsiella pneumoniae nosocomial outbreak in the United Kingdom. Microbiol Res. (2025) 16:90. doi: 10.3390/microbiolres16050090 Shah AA Alwashmi ASS Abalkhail A Alkahtani AM . Emerging challenges in Klebsiella pneumoniae: Antimicrobial resistance and novel approach. Microbial Pathogenesis. (2025) 202:107399. doi: 10.1016/j.micpath.2025.107399, PMID: 39983881 Tamma PD Aitken SL Bonomo RA Mathers AJ van Duin D Clancy CJ . Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. (2023) ciad428. doi: 10.1093/cid/ciad428, PMID: 37463564 Bonnin RA Jeannot K Santerre Henriksen A Quevedo J Dortet L . In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives. Clin Microbiol Infect. (2025) 31:240–9. doi: 10.1016/j.cmi.2024.09.031, PMID: 39374655 Lai C Ma Z Zhang J Junjun W Jinghui W Wu Z . Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis. Syst Rev. (2024) 13:309. doi: 10.1186/s13643-024-02695-x, PMID: 39702227 Kortright KE Chan BK Koff JL Turner PE . Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe. (2019) 25:219–32. doi: 10.1016/j.chom.2019.01.014, PMID: 30763536 Aslam B Asghar R Muzammil S Shafique M Siddique AB Khurshid M . AMR and Sustainable Development Goals: at a crossroads. Global Health. (2024) 20:73. doi: 10.1186/s12992-024-01046-8, PMID: 39415207 Ahmed SK Hussein S Qurbani K Ibrahim RH Fareeq A Mahmood KA . Antimicrobial resistance: Impacts, challenges, and future prospects. J Medicine Surgery Public Health. (2024) 2:100081. doi: 10.1016/j.glmedi.2024.100081 Idrees EK Aldriwesh MG Alkhulaifi MM Alghoribi MF . Systematic review of multidrug-resistant Klebsiella pneumoniae in the Arabian Peninsula: molecular epidemiology and resistance patterns. Front Microbiol. (2025) 16:1489317. doi: 10.3389/fmicb.2025.1489317, PMID: 39927260 Li X-L Hu Y-J Wang H Yu B-Q Yue H-L . Molecular spectroscopy evidence of berberine binding to DNA: comparative binding and thermodynamic profile of intercalation. Biomacromolecules. (2012) 13:873–80. doi: 10.1021/bm2017959, PMID: 22316074 Li Y Wen H Ge X . Hormesis Effect of Berberine against Klebsiella pneumoniae Is Mediated by Up-Regulation of the Efflux Pump KmrA. J Nat Prod. (2021) 84:2885–92. doi: 10.1021/acs.jnatprod.1c00642, PMID: 34665637 Wang Z Ding Z Li Z Ding Y Jiang F Liu J . Antioxidant and antibacterial study of 10 flavonoids revealed rutin as a potential antibiofilm agent in Klebsiella pneumoniae strains isolated from hospitalized patients. Microbial Pathogenesis. (2021) 159:105121. doi: 10.1016/j.micpath.2021.105121, PMID: 34343655 Dias C Aires A Saavedra MJ . Antimicrobial activity of isothiocyanates from cruciferous plants against methicillin-resistant Staphylococcus aureus (MRSA). Int J Mol Sci. (2014) 15:19552–61. doi: 10.3390/ijms151119552, PMID: 25353177 Romeo L Iori R Rollin P Bramanti P Mazzon E . Isothiocyanates: an overview of their antimicrobial activity against human infections. Molecules. (2018) 23:624. doi: 10.3390/molecules23030624, PMID: 29522501 Taher N . Synergistic effect of propolis extract and antibiotics on multi-resist klebsiella pneumoniae strain isolated from wound. Adv Life Sci Technol. (2015) 43:23–28. Khodaie L Patel P Deore S Surana V Byahatti V . Chapter 4 - Synergistic effects of plant extracts for antimicrobial therapy. In: Kaneria M Rakholiya K , editors. Herbal formulations, phytochemistry and pharmacognosy, drug discovery update. Amsterdam, Netherlands: Elsevier (2024). p. 55–76. doi: 10.1016/B978-0-443-15383-9.00005-6 Sun J Zeng Q Wu Z Huang L Sun T Ling C . Berberine inhibits NLRP3 inflammasome activation and proinflammatory macrophage M1 polarization to accelerate peripheral nerve regeneration. Neurotherapeutics. (2024) 21:e00347. doi: 10.1016/j.neurot.2024.e00347, PMID: 38570276 Jan R Khan M Asaf S Asif S Kim K-M . Bioactivity and therapeutic potential of kaempferol and quercetin: new insights for plant and human health. Plants (Basel). (2022) 11:2623. doi: 10.3390/plants11192623, PMID: 36235488 Kong F Ye B Cao J Cai X Lin L Huang S . Curcumin represses NLRP3 inflammasome activation via TLR4/myD88/NF-κB and P2X7R signaling in PMA-induced macrophages. Front Pharmacol. (2016) 7:369. doi: 10.3389/fphar.2016.00369, PMID: 27777559 Guo L Yue M Ma C Wang Y Hou J Li H . Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis. Heliyon. (2024) 10:e29361. doi: 10.1016/j.heliyon.2024.e29361, PMID: 38628726 Zong Y Sun L Liu B Deng Y-S Zhan D Chen Y-L . Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells. PloS One. (2012) 7:e44107. doi: 10.1371/journal.pone.0044107, PMID: 22952890 Hajibonabi A Yekani M Sharifi S Nahad JS Dizaj SM Memar MY . Antimicrobial activity of nanoformulations of carvacrol and thymol: New trend and applications. OpenNano. (2023) 13:100170. doi: 10.1016/j.onano.2023.100170 Moo C-L Osman MA Yang S-K Yap W-S Ismail S Lim S.-H.-E. . Antimicrobial activity and mode of action of 1,8-cineol against carbapenemase-producing Klebsiella pneumoniae. Sci Rep. (2021) 11:20824. doi: 10.1038/s41598-021-00249-y, PMID: 34675255 Sah SK Rasool U Hemalatha S . Andrographis paniculata extract inhibit growth, biofilm formation in multidrug resistant strains of Klebsiella pneumoniae. J Tradit Complement Med. (2019) 10:599–604. doi: 10.1016/j.jtcme.2019.02.006, PMID: 33134137 Barik CS Kanungo SK Tripathy NK Padhi M . The efficacy of herbs against Klebsiella pneumoniae with special reference to polyherbal formulation: An update. Surat, Gujarat, India: Pharma Science Monitor (2014). Luna-Pineda VM Rodríguez-Martínez G Salazar-García M Romo-Castillo M . Plant-origin components: new players to combat antibiotic resistance in klebsiella pneumoniae. Int J Mol Sci. (2024) 25:2134. doi: 10.3390/ijms25042134, PMID: 38396811 Chen X Song M Tian L Shan X Mao C Chen M . A plant peptide with dual activity against multidrug-resistant bacterial and fungal pathogens. Sci Adv. (2025) 11:eadt8239. doi: 10.1126/sciadv.adt8239, PMID: 40106560 Adeosun IJ Baloyi IT Cosa S . Anti-Biofilm and Associated Anti-Virulence Activities of Selected Phytochemical Compounds against Klebsiella pneumoniae. Plants (Basel). (2022) 11:1429. doi: 10.3390/plants11111429, PMID: 35684202 Gonfa YH Tessema FB Bachheti A Rai N Tadesse MG Nasser Singab A . Anti-inflammatory activity of phytochemicals from medicinal plants and their nanoparticles: A review. Curr Res Biotechnol. (2023) 6:100152. doi: 10.1016/j.crbiot.2023.100152 Akorful RAA Asafo-Adjei K Kotey FCN Donkor ES . Effectiveness of African herbal preparations against multidrug-resistant Klebsiella pneumoniae: A systematic review. Sci Afr. (2025) 28:e02644. doi: 10.1016/j.sciaf.2025.e02644 Das SN Mishra AK . Comparing phytochemicals and conventional antibiotics: mechanisms, affinities, and therapeutic potential review. J Res Appl Sci Biotechnol. (2025) 4:27–34. doi: 10.55544/jrasb.4.3.4 Popoola PO Ijibadejo MS Adejumo DO Efeurhobo OD Ogunleye OO Olawumi LT . Therapeutic potentials of phytochemicals in combatting antimicrobial resistance (AMR). Asian J Res Biochem. (2025) 15:48–62. doi: 10.9734/ajrb/2025/v15i1350 Liu X Bin C Zhou Z Zeng T Wu K Luo Y . The neurobiology of plant-based therapeutics in women’s reproductive health: mechanisms, efficacy, and clinical translation. Front Nutr. (2025) 12:1591534. doi: 10.3389/fnut.2025.1591534, PMID: 40463464 Shirzadi R Bayan AM Mosawi SH . Deciphering curcumin’s differential inhibition of KPC-3, L2, and CTX-M-15 β-lactamases through binding energetics and structural dynamics. In Silico Pharmacol. (2025) 13:128. doi: 10.1007/s40203-025-00421-6, PMID: 40917522 Zeppa L Aguzzi C Morelli MB . Exploring the therapeutic potential of natural compounds and plant extracts in human health. Biomolecules. (2025) 15:774. doi: 10.3390/biom15060774, PMID: 40563415 Hu Y Lin Q Zhao H Li X Sang S McClements DJ . Bioaccessibility and bioavailability of phytochemicals: Influencing factors, improvements, and evaluations. Food Hydrocolloids. (2023) 135:108165. doi: 10.1016/j.foodhyd.2022.108165 Hussain Y Alam W Ullah H Dacrema M Daglia M Khan H . Antimicrobial potential of curcumin: therapeutic potential and challenges to clinical applications. Antibiotics (Basel). (2022) 11:322. doi: 10.3390/antibiotics11030322, PMID: 35326785 Karthikeyan A Senthil N Min T . Nanocurcumin: A promising candidate for therapeutic applications. Front Pharmacol. (2020) 11:487. doi: 10.3389/fphar.2020.00487, PMID: 32425772 Süntar I Yakıncı Ö.F. Nabavi SM Suntar I Barreca D Khan H . Chapter Six - Potential risks of phytonutrients associated with high-dose or long-term use. In: Phytonutrients in food, woodhead publishing series in food science, technology and nutrition. Cambridge, UK: Woodhead Publishing (2020). p. 137–55. doi: 10.1016/B978-0-12-815354-3.00010-1 Zouine N Ghachtouli NE Abed SE Koraichi SI . A comprehensive review on medicinal plant extracts as antibacterial agents: Factors, mechanism insights and future prospects. Sci Afr. (2024) 26:e02395. doi: 10.1016/j.sciaf.2024.e02395 Kaundal R Kumar D . Current demands for standardization of Indian medicinal plants: A critical review. Med Drug Discov. (2025) 27:100211. doi: 10.1016/j.medidd.2025.100211 An Y Sun J-X Ma S-Y Xu M-Y Xu J-Z Liu C-Q . From plant based therapy to plant-derived vesicle-like nanoparticles for cancer treatment: past, present and future. Int J Nanomedicine. (2025) 20:3471–91. doi: 10.2147/IJN.S499893, PMID: 40125436 Dutt Y Pandey RP Dutt M Gupta A Vibhuti A Raj VS . Liposomes and phytosomes: Nanocarrier systems and their applications for the delivery of phytoconstituents. Coordination Chem Rev. (2023) 491:215251. doi: 10.1016/j.ccr.2023.215251 Purohit P Mishra P . Phytosomes as innovative delivery systems for phytochemicals: An updated review. Int J Pharm Res Dev. (2025) 7:16–25. doi: 10.33545/26646862.2025.v7.i1a.89 Kim HK Kim SJ Gil WJ Yang C-S . Exploring the therapeutic potential of phytochemicals: challenges and strategies for clinical translation. Phytomedicine. (2025) 145:157090. doi: 10.1016/j.phymed.2025.157090, PMID: 40716124 Toews ML Bylund DB . Pharmacologic principles for combination therapy. Proc Am Thorac Soc. (2005) 2:282–9. doi: 10.1513/pats.200504-037SR, PMID: 16267349 Emmanuel AO Elabor I Limangba IJ . Phytochemical-antibiotic synergy: exploring the antibacterial potential of calotropis procera in combination therapy. Int J Sci Res Biol Sci. (2025) 12:24–31. doi: 10.26438/ijsrbs.v12i4.705 Chenxi Z Hemmat A Thi N Afrand M . Nanoparticle-enhanced drug delivery systems: An up-to-date review. J Mol Liquids. (2025) 424:126999. doi: 10.1016/j.molliq.2025.126999 Choudhury A . Potential role of bioactive phytochemicals in combination therapies against antimicrobial activity. J Pharmacopuncture. (2022) 25:79–87. doi: 10.3831/KPI.2022.25.2.79, PMID: 35837140

Edited by: Gabriela Cristina Fernandez, National Scientific and Technical Research Council (CONICET), Argentina

Reviewed by: Bhavana Gangwar, McMurry University, United States

Puneet Gandhi, Bhopal Memorial Hospital & Research Centre, India